Skip to main content
Intermediate Technical IVT

JSLE

Also written as: JSLE — Juvenile-onset Systemic Lupus Erythematosus

Juvenile-onset Systemic Lupus Erythematosus, referring to systemic lupus erythematosus with onset before age 18.

Full Definition

Juvenile-onset Systemic Lupus Erythematosus (JSLE) is a multisystem autoimmune disease that begins before age 18, characterized by more severe organ involvement and worse prognosis compared to adult-onset disease. JSLE affects approximately 10-20% of all lupus patients and frequently involves renal, neuropsychiatric, and hematologic manifestations. The disease tends to be more aggressive in children and adolescents, with higher rates of lupus nephritis, seizures, and other serious complications. Treatment requires careful balance between disease control and minimizing medication-related toxicity in growing children, making JSLE management particularly challenging in pediatric rheumatology practice.

Usage

Usage note: Prefer 'JSLE' over 'pediatric lupus' in clinical documentation for precision about age of onset.

In Context

  • "The patient's JSLE presentation included nephritis and thrombocytopenia at diagnosis." — Case presentation
  • "Long-term follow-up protocols for JSLE include regular monitoring for organ damage accrual." — Clinical guidelines

Also known as

childhood lupus pediatric SLE

Don't confuse with

pediatric lupus childhood-onset lupus

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON